scispace - formally typeset
F

Florentia Kaguelidou

Researcher at French Institute of Health and Medical Research

Publications -  77
Citations -  2054

Florentia Kaguelidou is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 18, co-authored 58 publications receiving 1662 citations. Previous affiliations of Florentia Kaguelidou include Erasmus University Medical Center & University of Paris.

Papers
More filters
Journal ArticleDOI

Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units.

TL;DR: The purpose of this study was to determine the risk factors for sepsis, the causative organisms, and mortality following infection in a large and diverse sample of NICUs, and to conclude that overall mortality in VLBW infants with early- and late-onset sepsi is higher than in infants with negative cultures.
Journal ArticleDOI

Long-Term Mortality after Recombinant Growth Hormone Treatment for Isolated Growth Hormone Deficiency or Childhood Short Stature: Preliminary Report of the French SAGhE Study

TL;DR: Mortality rates were increased in this population of adults treated as children with recombinant GH, particularly in those who had received the highest doses, highlighting the need for additional studies of long-term mortality and morbidity after GH treatment in childhood.
Journal ArticleDOI

Predictive factors for success after transnasal endoscopic treatment of choanal atresia.

TL;DR: Transnasal endoscopic repair of CA is a safe and successful technique and Predictive factors of restenosis are the presence of GERD, age younger than 10 days at the time of surgery, and insufficient postoperative endoscopic revision, however, previous surgery and associated malformations are not predictive of a poor surgical outcome.
Journal ArticleDOI

Positive Impact of Long-Term Antithyroid Drug Treatment on the Outcome of Children with Graves' Disease: National Long-Term Cohort Study

TL;DR: About half the patients achieved remission after carbimazole discontinuation, and there seems to be a plateau in the incidence of remission achieved after 8-10 yr ATD therapy.